Program to reduce hospital readmissions linked with increased risk of death among HF patients
- Date:
- November 13, 2017
- Source:
- The JAMA Network Journals
- Summary:
- Implementation of a program designed to reduce hospital readmissions was associated with a reduction in the rate of readmissions, but also an increase in the rate of death among Medicare patients hospitalized with heart failure.
- Share:
Implementation of a program designed to reduce hospital readmissions was associated with a reduction in the rate of readmissions, but also an increase in the rate of death among Medicare patients hospitalized with heart failure, shows a study of 115,245 fee-for-service Medicare patients from 416 hospital sites. The study was conducted between January 2006 through December 2014 divided into periods before (January 1, 2006 to March 31, 2010), during (April 1, 2010 to September 30, 2012) and after HRRP penalties went into effect (October 1, 2012 to December 31, 2014), to measure risk of hospital readmission or death 30 days and one year after discharge, supervised by Gregg C. Fonarow, M.D., of the Ronald Reagan-UCLA Medical Center, Los Angeles, and Associate Editor of the Health Care Quality and Guidelines section, JAMA Cardiology, and coauthors.
Heart failure is the leading cause of readmissions among Medicare patients. The Affordable Care Act of 2010 established the Hospital Readmissions Reduction Program (HRRP), which involved public reporting of hospitals' 30-day readmission rates for heart failure, heart attack, and pneumonia and created financial penalties for hospitals with higher readmissions. However, incentives to reduce readmissions can potentially encourage inappropriate care strategies and may adversely affect patient outcomes.
This was an observational study. In observational studies, researchers observe exposures and outcomes for patients as they occur naturally in clinical care or real life. Because researchers are not intervening for purposes of the study they cannot control natural differences that could explain study findings so they cannot prove a cause-and-effect relationship.
Commenting on study limitations, researchers say that this is an analysis of heart failure hospitalizations from hospitals participating voluntarily in a heart failure clinical registry and may not be generalizable to other hospitals. This is a patient-level analysis of readmissions and mortality and does not directly establish the association of change in readmission rate at a given hospital with change in its mortality rate.
These findings raise concerns that the HRRP, while achieving desired reductions in readmissions, may be associated with compromised survival of patients with heart failure. If the findings are confirmed they may require reconsideration of use of the HRRP penalties program for patients with heart failure.
Story Source:
Materials provided by The JAMA Network Journals. Note: Content may be edited for style and length.
Journal Reference:
- Ankur Gupta, Larry A. Allen, Deepak L. Bhatt, Margueritte Cox, Adam D. DeVore, Paul A. Heidenreich, Adrian F. Hernandez, Eric D. Peterson, Roland A. Matsouaka, Clyde W. Yancy, Gregg C. Fonarow. Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure. JAMA Cardiology, 2017; DOI: 10.1001/jamacardio.2017.4265
Cite This Page: